Hema Diagnostic Systems' Corporate Majority Round

Hema Diagnostic Systems raised a round of funding on September 30, 2015. Investors include Generex Biotechnology.

Hema Diagnostic Systems has designed, engineered, and manufactured a series of new rapid diagnostic tests for infectious diseases that include hepatitis B, hepatitis C, malaria, HIV, tuberculosis, syp…

Articles about Hema Diagnostic Systems' Corporate Majority Round: